GRB14 and cancer: As in MEFs, deletion of IMP2 from the cancer cell lines is accompanied by a marked increase in the abundance of Grb14 and IGFBP2 (Figure 4A), and overexpression of IMP2 reduces the abundance of both the IGFBP2 and Grb14 polypeptides (Figure 4B).